Detection of ventricular fibrillation in implantable defibrillators with automatic gain control amplifiers. Effects of programming sensitivity

Europace

Volumn 2, Issue 2, 2000, Pages 160-162

  Schulte, B ^a   Sperzel, J ^a   Schwarz, T ^a   Pitschner, H F ^a   Strupp, G ^b   Neuzner, J ^a  

^a KERCKHOFF HEART CENTER   (Germany)

^b Medical Clinic I   (Germany)

Author keywords

Automatic gain control; Implantable defibrillator; Programmable sensitivity

Indexed keywords

AMPLIFIER; ARTICLE; CLINICAL TRIAL; DEFIBRILLATOR; EQUIPMENT DESIGN; FEMALE; HEART VENTRICLE FIBRILLATION; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; SENSITIVITY AND SPECIFICITY;

AMPLIFIERS; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT DESIGN; FEMALE; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; VENTRICULAR FIBRILLATION;

EID: 0034172884     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1053/eupc.1999.0083     Document Type: Article

References (12)

1. Leitch JW, Yee R, Klein GJ, Jones DL, Murdock CJ. Correlation between the ventricular electrogram amplitude in sinus rhythm and in ventricular fibrillation. PACE. 13:1990;1105-1109.
2. Sperry RE, Ellenbogen KA, Wood MA, Stambler BS, DiMarco JP, Haines DE. Failure of a second and third generation implantable cardioverter defibrillator to sense ventricular tachycardia: implications for fixed-gain sensing devices. PACE. 15:1992;749-755.
3. Reiter MJ, Mann DE. Sensing and tachyarrhythmia detection problems in implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 7:1996;542-558.
4. Callans DJ, Hook BG, Kleimann RB, Mitra RL, Flores BT, Marchlinski FE. Unique sensing errors in third-generation implantable cardioverter-defibrillator. J Am Coll Cardiol. 22:1993;1135-1140.
5. Rosenthal ME, Paskmann C. Noise detection during bradycardia pacing with a hybrid nonthoracotomy implantable cardioverter defibrillator system: incidence and clinical significance. PACE. 21:1998;1380-1386.
6. Kelly PA, Mann DE, Damle RS, Reiter MJ. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator. J Am Coll Cardiol. 23:1994;1531-1534.
7. Brumwell, DA, Kroll, MW, Lehmann, MH, The amplifier: sensing the depolarization. In: Kroll MW, Lehmann MH, eds. Implantable cardioverter defibrillator therapy. The engineering-clinical interference. Norwell, U S A, Kluwer Academic Publishers: 275, 392.
8. Deshmukh P, Anderson K. Myopotential sensing by a dual chamber implantable cardioverter defibrillator: Two case reports. J Cardiovasc Electrophysiol. 9:1998;767-772.
9. Neuzner J, Dürsch M, Sperzel J, Schwarz T, König S, Pitschner HF. Myopotential sensing: cause of inappropriate arrhythmia detection and device discharges in implantable defibrillator therapy (Abstr). PACE. 20:1997;1225.
10. Barold SS, Ong LSA, Falkoff MD, Heinle RA. Inhibition of bipolar demand pacemaker by diaphragmatic myopotentials. Circulation. 56:1977;679-683.
11. Ellenbogen KA, Wood MA, Stambler BS, Welch WJ, Damiano RJ. Measurement of ventricular electrogram amplitude during intraoperative induction of ventricular tachyarrhythmias. Am J Cardiol. 70:1992;1017-1022.
12. Goldberger JJ, Horvath G, Donovan D, Johnson D, Challapalli R, Kadish AH. Detection of ventricular fibrillation by transvenous defibrillating leads: Integrated versus dedicated bipolar sensing. J Cardiovasc Electrophysiol. 9:1998;677-688.